K151315 is an FDA 510(k) clearance for the Expect Pulmonary Endobronchial Ultrasound Transbronchial Aspiration Needle. Classified as Bronchoscope (flexible Or Rigid) (product code EOQ), Class II - Special Controls.
Submitted by Boston Scientific Corporation (Marlboro, US). The FDA issued a Cleared decision on November 10, 2015 after a review of 176 days - an extended review cycle.
This device falls under the Ear, Nose, Throat FDA review panel, regulated under 21 CFR 874.4680 - the FDA ear, nose and throat device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Ear, Nose, Throat review framework, consistent with the majority of Class II 510(k) submissions.
View all Boston Scientific Corporation devices